These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31884469)

  • 1. Revisiting Criteria for Psychosis in Alzheimer's Disease and Related Dementias: Toward Better Phenotypic Classification and Biomarker Research.
    Fischer CE; Ismail Z; Youakim JM; Creese B; Kumar S; Nuñez N; Ryan Darby R; Di Vita A; D'Antonio F; de Lena C; McGeown WJ; Ramit R; Rasmussen J; Bell J; Wang H; Bruneau MA; Panegyres PK; Lanctôt KL; Agüera-Ortiz L; Lyketsos C; Cummings J; Jeste DV; Sano M; Devanand DP; Sweet RA; Ballard C
    J Alzheimers Dis; 2020; 73(3):1143-1156. PubMed ID: 31884469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Criteria for Psychosis in Major and Mild Neurocognitive Disorders: International Psychogeriatric Association (IPA) Consensus Clinical and Research Definition.
    Cummings J; Pinto LC; Cruz M; Fischer CE; Gerritsen DL; Grossberg GT; Hwang TJ; Ismail Z; Jeste DV; Koopmans R; Lanctot KL; Mateos R; Peschin S; Sampaio C; Tsuang D; Wang H; Zhong K; Bain LJ; Sano M
    Am J Geriatr Psychiatry; 2020 Dec; 28(12):1256-1269. PubMed ID: 32958332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future.
    Geda YE; Schneider LS; Gitlin LN; Miller DS; Smith GS; Bell J; Evans J; Lee M; Porsteinsson A; Lanctôt KL; Rosenberg PB; Sultzer DL; Francis PT; Brodaty H; Padala PP; Onyike CU; Ortiz LA; Ancoli-Israel S; Bliwise DL; Martin JL; Vitiello MV; Yaffe K; Zee PC; Herrmann N; Sweet RA; Ballard C; Khin NA; Alfaro C; Murray PS; Schultz S; Lyketsos CG;
    Alzheimers Dement; 2013 Sep; 9(5):602-8. PubMed ID: 23562430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring Psychosis in Neurodegenerative Dementia: Connecting Symptoms to Neurobiology.
    Morrow CB; Pontone GM
    J Alzheimers Dis; 2024; 99(1):101-103. PubMed ID: 38669552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychosis and dementia: risk factor, prodrome, or cause?
    Fischer CE; Agüera-Ortiz L
    Int Psychogeriatr; 2018 Feb; 30(2):209-219. PubMed ID: 28560931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosis in Alzheimer disease - mechanisms, genetics and therapeutic opportunities.
    Ismail Z; Creese B; Aarsland D; Kales HC; Lyketsos CG; Sweet RA; Ballard C
    Nat Rev Neurol; 2022 Mar; 18(3):131-144. PubMed ID: 34983978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosis in Neurodegenerative Dementias: A Systematic Comparative Review.
    Cressot C; Vrillon A; Lilamand M; Francisque H; Méauzoone A; Hourregue C; Dumurgier J; Marlinge E; Paquet C; Cognat E
    J Alzheimers Dis; 2024; 99(1):85-99. PubMed ID: 38669539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003.
    Ropacki SA; Jeste DV
    Am J Psychiatry; 2005 Nov; 162(11):2022-30. PubMed ID: 16263838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lewy Bodies, Vascular Risk Factors, and Subcortical Arteriosclerotic Leukoencephalopathy, but not Alzheimer Pathology, are Associated with Development of Psychosis in Alzheimer's Disease.
    Fischer CE; Qian W; Schweizer TA; Millikin CP; Ismail Z; Smith EE; Lix LM; Shelton P; Munoz DG
    J Alzheimers Dis; 2016; 50(1):283-95. PubMed ID: 26682680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of depression and psychosis in Alzheimer's disease.
    Wragg RE; Jeste DV
    Am J Psychiatry; 1989 May; 146(5):577-87. PubMed ID: 2653053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosis of Alzheimer's disease: clinical characteristics and history.
    Schneider LS; Dagerman KS
    J Psychiatr Res; 2004 Jan; 38(1):105-11. PubMed ID: 14690773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosis associated behavioral and psychological signs and symptoms in mild cognitive impairment and Alzheimer's dementia.
    Van der Mussele S; Mariën P; Saerens J; Somers N; Goeman J; De Deyn PP; Engelborghs S
    Aging Ment Health; 2015; 19(9):818-28. PubMed ID: 25323000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Cerebrovascular Disease on Cognitive and Functional Status and Psychosis in Severe Alzheimer's Disease.
    Kim J; Schweizer TA; Fischer CE; Munoz DG
    J Alzheimers Dis; 2017; 55(1):381-389. PubMed ID: 27662301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of olanzapine in reducing the emergence of psychosis among nursing home patients with Alzheimer's disease.
    Clark WS; Street JS; Feldman PD; Breier A
    J Clin Psychiatry; 2001 Jan; 62(1):34-40. PubMed ID: 11235926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
    Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ
    Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case series of mild behavioral impairment: toward an understanding of the early stages of neurodegenerative diseases affecting behavior and cognition.
    Cieslak A; Smith EE; Lysack J; Ismail Z
    Int Psychogeriatr; 2018 Feb; 30(2):273-280. PubMed ID: 29017626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Right hippocampus atrophy is independently associated with Alzheimer's disease with psychosis.
    Lee K; Lee YM; Park JM; Lee BD; Moon E; Jeong HJ; Kim SY; Chung YI; Kim JH
    Psychogeriatrics; 2019 Mar; 19(2):105-110. PubMed ID: 30430708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.